Cancer
Checkmate 7DX
A Study of Nivolumab or Placebo in Combination with Docetaxel in Men with Metastatic Castration-resistant Prostate Cancer - CheckMate 7DX
Trial overview
Description
The purpose of this study is to assess the safety and effectiveness of nivolumab with docetaxel in men with advanced castration resistant prostate cancer who have progressed after second-generation hormonal manipulation
Study details
For detailed information on this trial, please click here
Trial status
Actively recruiting
Location
Priniciple Investigator
